News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Timothée Olivier: FRESCO-2 trial and Fruquintinib
Timothée Olivier/X
Jun 9, 2025, 08:13

Timothée Olivier: FRESCO-2 trial and Fruquintinib

Timothée Olivier, Medical Oncologist at the Oncology Division of Geneva University Hospital in Switzerland, shared an article on X:

“Our new work out in Translational Oncology, led by Sruthi Ranganathan again!!

A pure product from VKPrasadLab Vinay Prasad.

FRESCO-2 is potentially problematic due to the suboptimal use of placebo, and due to the poor cost-effectiveness of fruquintinib.

Full article here”

FRESCO–2 trial and fruquintinib: A clearer picture of the control arm.

Authors: Sruthi Ranganathan, Alyson Haslam, Timothée Olivier, Vinay Prasad.

You can read the full article on Journal of Translational Oncology.

Timothée Olivier: FRESCO-2 trial and Fruquintinib

More posts featuring Timothée Olivier.

Alyson Haslam cancer fight against cancer FRESCO-2 Fruquintinib Geneva University Hospital Global fight against cancer MedOnc OncoDaily Oncology Sruthi Ranganathan Timothée Olivier Translational Oncology Vinay Prasad VKPrasadLab
Special Coverage
Science
Jun 9, 2025, 08:13
Timothée Olivier: FRESCO-2 trial and Fruquintinib
Blog
Jun 9, 2025, 08:12
From Words to Action: Fatty Liver and NCDs at the Heart of EU Policy - ELPA
Blog
Jun 9, 2025, 08:04
Lauren Ridgley Shares Father’s Story of Small-Cell Lung Cancer at Providence Event
Blog
Jun 9, 2025, 07:52
Isabel Mestres: At C/Can, We Believe Cities are more than Implementation Sites, they are Living Laboratories of the Health System
Blog
Jun 9, 2025, 07:49
Amol Akhade: Must-Read for All - Oncologists and Non Oncologists
Blog
Jun 9, 2025, 07:45
Register today for ESMO Immuno-Oncology Annual Congress - European Society for Medical Oncology
Blog
Jun 9, 2025, 07:43
Dana-Farber’s Breast Oncology Center - Novel and Emerging Treatment Options in ER+/HER2− Metastatic Breast Cancer
Science
Jun 9, 2025, 07:29
Diego Díaz García Highlights LAG-3 as Emerging Checkpoint Target in Melanoma
Blog
Jun 9, 2025, 07:23
Aaron Goodman Reflects on Discomfort and Imposter Syndrome in Medical Practice
Blog
Jun 9, 2025, 07:12
Yan Leyfman: Are Immune Checkpoint Inhibitors Safe for Patients with Neurologic Autoimmune Disorders?
Blog
Jun 9, 2025, 07:07
Paolo Tarantino Raises Poll on Chemotherapy Attrition in Metastatic Breast Cancer
Blog
Jun 9, 2025, 05:26
Diego Sadler Reports FDOH Grant for Cancer Innovation to GCOR